A

Alto Neuroscience

66 employees

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neuroscience
Health Care
Artificial Intelligence
Biopharma

Date founded

2019

Funding rounds raised

Total raised

$35M

from 18 investors over 18 rounds

A

Alto Neuroscience raised $35M on January 30, 2023

Investors: K2 HealthVentures

A

Alto Neuroscience raised $35M on October 25, 2022

Investors: Valor Equity Partners, infinitas capital, Vine Ventures, L.P., Presight Capital, Windham Venture Partners, Korify Capital AG, The Sobrato Organization and Novartis Japan

A

Alto Neuroscience raised undisclosed on March 18, 2022

Investors: Bioverge

A

Alto Neuroscience raised undisclosed on May 24, 2021

Investors: NJF Capital

A

Alto Neuroscience raised $32M on May 3, 2021

Investors: Risk and Return, Apeiron Investment Group, Korify Capital AG, __able, Windham Venture Partners and Presight Capital

A

Alto Neuroscience raised undisclosed on January 1, 2020

Investors: -

FAQ